Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 22;8(4):73.
doi: 10.3390/brainsci8040073.

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

Affiliations
Review

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

Fabrizio Schifano et al. Brain Sci. .

Abstract

Recently, a range of prescription and over-the-counter drugs have been reportedly used as Novel Psychoactive Substances (NPS), due to their potential for abuse resulting from their high dosage/idiosyncratic methods of self-administration. This paper provides a systematic review of the topic, focusing on a range of medications which have emerged as being used recreationally, either on their own or in combination with NPS. Among gabapentinoids, pregabalin may present with higher addictive liability levels than gabapentin, with pregabalin being mostly identified in the context of opioid, polydrug intake. For antidepressants, their dopaminergic, stimulant-like, bupropion activities may explain their recreational value and diversion from the therapeutic intended use. In some vulnerable clients, a high dosage of venlafaxine (‘baby ecstasy’) is ingested for recreational purposes, whilst the occurrence of a clinically-relevant withdrawal syndrome may be a significant issue for all venlafaxine-treated patients. Considering second generation antipsychotics, olanzapine appears to be ingested at very large dosages as an ‘ideal trip terminator’, whilst the immediate-release quetiapine formulation may possess proper abuse liability levels. Within the image- and performance- enhancing drugs (IPEDs) group, the beta-2 agonist clenbuterol (‘size zero pill’) is reported to be self-administered for aggressive slimming purposes. Finally, high/very high dosage ingestion of the antidiarrhoeal loperamide has shown recent increasing levels of popularity due to its central recreational, anti-withdrawal, opiatergic effects. The emerging abuse of prescription drugs within the context of a rapidly modifying drug scenario represents a challenge for psychiatry, public health and drug-control policies.

Keywords: NPS; drug abuse; novel psychoactive substances; pharmacovigilance; prescribing drugs’ abuse.

PubMed Disclaimer

Conflict of interest statement

F.S. is the guest editor of this special issue; an Advisory Council on the Misuse Drugs (ACMD) member, UK; and an EMA Advisory board (psychiatry) member. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

Figures

Figure 1
Figure 1
Selection of retrieved studies.

References

    1. Schifano F., Orsolini L., Papanti D., Corkery J.M. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14:15–26. doi: 10.1002/wps.20174. - DOI - PMC - PubMed
    1. United Nations Office for Drugs and Crime (UNODC) Early Warning Advisory on New Psychoactive Substances. [(accessed on 20 January 2018)]; Available online: https://www.unodc.org/LSS/Page/NPS.
    1. European Monitoring Centre for Drugs and Drug Abuse (EMCDDA) European Drug Report. Trends and Developments. EMCDDA; Lisbon, Portugal: 2017. [(accessed on 2 March 2018)]. Available online: http://www.emcdda.europa.eu/system/files/publications/4541/TDAT17001ENN.pdf.
    1. Zawilska J.B., Andrzejczak D. Next generation of novel psychoactive substances on the horizon—A complex problem to face. Drug Alcohol Depend. 2015;157:1–17. doi: 10.1016/j.drugalcdep.2015.09.030. - DOI - PubMed
    1. Van Hout M.C., Hearne E. New psychoactive substances (NPS) on crypto market fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. Int. J. Drug Policy. 2017;40:102–110. doi: 10.1016/j.drugpo.2016.11.007. - DOI - PubMed

LinkOut - more resources